Response Genetics, Inc. to Present at the 2013 UBS Global Healthcare Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES, May 8, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, announced today that Thomas A. Bologna, Chairman and CEO, will present at the 2013 UBS Global Healthcare Conference in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC